Global Handheld Melanoma Scanner Market Size, Share, Trensd, Industry Analysis, Regional Outlook, Demand & Growth Opportunities Assessment, And Forecast 2017-2025

Global Handheld Melanoma Scanner Market 

Market Overview                            

Melanoma is a type of tumor that develop in melanocytes (a deep epidermal cells that produce pigment melanin), which in case if detected at an early stage i.e. less than 1mm deep will lead to 5 year survival rate of 93% to 97% and with the advanced disease stage, the survival rate drops to 10% to 20%. Therefore, in order to sanction early detection to evade unwanted biopsies, there is a requirement for precise diagnostic devices that can distinct benign skin lesions from malignant ones. Melanoma is the seventh most common cancer in Canada with about 6,000 new cases estimated in 2013 (3,300 men and 2,700 women) and an age-standardized incidence rate of 13.4 per 100,000 people (15.1 for men and 12.2 for women).

Goldstein Research analyst forecast the handheld melanoma scanner market size is set to reach USD 650 million by 2025, at a CAGR of 8.12% over the forecast years. High investment by skin cancer diagnostic & therapeutic companies and increasing number of pipeline products for cancer diagnosis under clinical trials are the key factors which are driving the growth of market of handheld melanoma scanners.

Intended Audience

• Handheld Melanoma Scanner Suppliers
• Handheld Melanoma Scanner Manufacturers
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Diagnostic Centers
• Business consultancies
• Venture capitalists
• Public and private health agencies

Covered In This Handheld Melanoma Scanner Market Report    

The report covers the present ground scenario and the future growth prospects of the Handheld Melanoma Scanner market for 2017-2025 along with the data of shipments of handheld melanoma scanner worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The Handheld Melanoma Scanner market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Global Handheld Melanoma Scanner Market Segmentation

By Patient Group Skin Melanoma

• Superficial Spreading Melanoma
• Nodular Melanoma
• Lentigo Maligna
• Acral Lentiginous Melanoma

By End User

• Hospitals
• Clinics
• Cancer Research Organizations

Based on Geography

• North America (U.S. & Canada)  Handheld Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest of Latin America)  Handheld Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE)  Handheld Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia)  Handheld Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA)  Handheld Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}

Based on patient group skin melanoma, the most typical form of melanoma is superficial spreading melanoma which comprises 65% market share of total patient group skin melanoma’s, which often arises in a pre-existing mole and grows parallel before invading in upright manner. Furthermore, 25% patient group suffers from nodular melanomas that bypass the horizontal growth phase.

Handheld Melanoma Scanner Market Industry - Trends, Share, & Drivers

Global Handheld Melanoma Scanner Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Handheld Melanoma Scanner market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global Handheld Melanoma Scanner market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our global handheld melanoma scanner market report comprises of the following companies as the key players: Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca.

According to our global market study on the basis of extensive primary and secondary research: “One trend is the instant diagnosis of melanoma with the flash of a light as early detection is the best defense. For instance, the Verisante Aura, a new device has been developed in Canada using a real-time laser system called Raman spectroscopy. It is a small but robust system that non-invasively analyzes a lesion/mole by scanning 21 different cancer biomarkers at the cellular level.”

According to the report, major driving factor is the growing skin cancer therapeutics market with increasing prevalence of melanoma skin cancer cases. In the United States 76,250 men and women were diagnosed and 9,180 men and women died of melanoma of the skin in 2012. Melanoma scanner creates multiple real- time digital images for dermatologists, physicians and skin specialists to evaluate various types of moles or lesions within seconds, in addition, handheld scanner is a part of non-invasive skin analysis system which provides color bitmaps that show the relative location of blood, collagen and melanin.

Further, the report states the biggest challenge is unavailability of handheld melanoma scanner and the trained staff in some of the emerging economies coupled with high treatment cost of melanoma skin cancer is restraining the growth of handheld melanoma scanner market.  

Based on geography, North America is anticipated to dominate the global melanoma market due to increasing cases of melanoma and presence of handheld melanoma scanner manufacturers in the region. MedX Health Corp. is a leading Canadian medical device company focused on skin cancer imaging and assessment and their patented technology uses light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain-free, non-invasive manner. Several non-invasive, automated, hand-held optical scanners have been developed to help dermatologists determine whether a skin biopsy is indicated is driving the Handheld Melanoma Scanner market in Europe and APAC regions.  

 The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Handheld Melanoma Scanner Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the revenue of total market in 2016-17 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.